Synthesis of Biodegradable Antimicrobial PH-sensitive Silver Nanocomposites Reliant on Chitosan and Carrageenan Derivatives for 5-fluorouracil Drug Delivery Toward HCT116 Cancer Cells
Overview
Affiliations
The current research relies on a one-pot green biosynthesis of silver nanoparticles (SNPs) with various ratios of silver (Ag) in the existence of N, N, N-trimethyl chitosan chloride (TMC) and carboxymethyl kappa-carrageenan (CMKC), to investigate the effectiveness of the synthesized silver nanocomposites (SNCs) as pH sensitive biodegradable carrier for orally intestinal delivery of 5-fluorouracil (5-FU) drug. FTIR, XRD, TEM and FE-SEM/EDX methods were utilized to demonstrate the structure of the prepared polyelectrolyte complex PEC (TMC/CMKC) and SNCs (TMC/CMKC/Ag). The results showed that the 5-FU encapsulation effectiveness inside all of the prepared SNCs samples was improved by increasing the concentration of Ag, reaching 92.16 ± 0.57 % with 3 % Ag. In vitro release behavior of 5-FU loaded SNC 3 % (TMC/CMKC/Ag 3 %), displayed slow and sustained release reaching 96.3 ± 0.81 % up to 24 h into pH 7.4 medium. The successful release of 5-FU from the loaded SNC 3 % was confirmed through occurrence of strong cytotoxicity, with an IC value of 31.15 μg/ml, and high % of apoptotic cells (30.66 %) within the treated HCT116 cells. Besides, SNC 3 % showed good biodegradability and antimicrobial properties against different bacterial strains. Overall, SNC 3 % can be suggested as an effective system for both controlled drug delivery and antibacterial action.
Dogan M Med Oncol. 2024; 41(11):251.
PMID: 39320578 DOI: 10.1007/s12032-024-02512-4.
El-Meligy M, Abd El-Monaem E, Eltaweil A, Mohy-Eldin M, Ziora Z, Heydari A Molecules. 2024; 29(10).
PMID: 38792255 PMC: 11124311. DOI: 10.3390/molecules29102393.
Ahmed T, Ahmed S, Elkhenany H, El-Desouky M, Magdeldin S, Osama A Stem Cell Res Ther. 2024; 15(1):36.
PMID: 38331889 PMC: 10854071. DOI: 10.1186/s13287-024-03643-1.
James J, Verma M, Sharma N World J Microbiol Biotechnol. 2023; 40(1):4.
PMID: 37923917 DOI: 10.1007/s11274-023-03787-x.
Inorganic Nanomaterials Used in Anti-Cancer Therapies:Further Developments.
Dlugosz O, Matyjasik W, Hodacka G, Szostak K, Matysik J, Krawczyk P Nanomaterials (Basel). 2023; 13(6).
PMID: 36986024 PMC: 10051539. DOI: 10.3390/nano13061130.